Wall Street Analysts Think Adverum Biotechnologies (ADVM) Could Surge 290.54%: Read This Before Placing a Bet

Adverum Biotechnologies (ADVM) closed the last trading session at $8.67, gaining 18.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 33.86 indicates a 290.5% upside potential.The average comprises seven short-term price targets ranging from a low of $20 to a high of$ 60, with a standard deviation of $14.05. While the lowest estimate indicates an increase of 130.7% from the curre ...